Brazil and China are the next target markets for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) as it expands geographically, the generic drugs giant's CEO Jeremy Levin declared yesterday at a conference held by investment house Canaccord Genuity. "We look to expand our geographic footprint where we feel that there are markets that we're not present in," said Levin, "And you should know we're not present in places like Brazil in any meaningful way. We're not present yet in the large expanding markets of China in any meaningful way."